| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.96M | $20.70M | - | |
| 10% | 2.96M | $20.70M | - | |
| CEO | 526.0K | $3.67M | - | |
| 10% | 381.3K | $2.66M | - | |
| Pres | 216.3K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2022 | Baker Bros. Advisors LP59 | 10% Owner | Buy | 71,944 | $5.99 | $430,700.75 | +0.4% | +105.0% | +109.3% | |
| Jan 12, 2022 | Crowley John F67 | Director | Buy | 5,000 | $9.72 | $48,575.00 | New | -27.3% | +40.9% | |
| Nov 2, 2021 | Mpm Bioventures 2014, L.P.67 | 10% Owner | Buy | 100,000 | $20.00 | $2,000,000.00 | +2.3% | -56.6% | -14.1% | |
| Nov 2, 2021 | Foley Todd82 | Director, 10% Owner | Buy | 100,000 | $20.00 | $2,000,000.00 | +2.3% | -56.6% | -14.1% | |
| Nov 2, 2021 | 5am Ventures V, L.P.72 | 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +28.3% | -56.6% | -14.1% | |
| Nov 2, 2021 | Mpm Bioventures 2018, L.P.54 | 10% Owner | Buy | 100,000 | $20.00 | $2,000,000.00 | +2.3% | -56.6% | -14.1% | |
| Nov 2, 2021 | Redmile Group, LLC | 10% Owner | Buy | 1,000,000 | $20.00 | $20,000,000.00 | +104.8% | -56.6% | -14.1% | |
| Nov 2, 2021 | Parmar Kush67 | Director, 10% Owner | Buy | 250,000 | $20.00 | $5,000,000.00 | +28.3% | -56.6% | -14.1% |